Vontobel certifikat
Tillbaka

MFS MRNA VT162

  • Symbol MFS MRNA VT162
  • ISIN DE000VX1XXK6
Knockades den  2021-10-26
Moderna Inc.USD 
Observera att detta endast är en indikation.

Dokument

Notice

BARRIER EVENT

ISIN: DE000VX1XXK6
NGM Symbol: MFS MRNA VT162

Barrier Event occurred on: 26/10/2021
Determined at: 15:31:18

Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Barrier: 351.19

Product Name: MFS MRNA VT162
Last trading day: 26/10/2021
Maturity Date: 08/11/2021
Cash Amount: 11.97 SEK
The price of the underlying has hit the barrier. The product shall be redeemed at the Maturity Date by payment of the Cash Amount and will be delisted after market closing today.

Frankfurt am Main, 26/10/2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.12

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 26.10.2021

Frankfurt am Main, 26.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.15

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.03%

Due date: 25.10.2021

Frankfurt am Main, 25.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.26

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.03%

Due date: 22.10.2021

Frankfurt am Main, 22.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.29

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.03%

Due date: 21.10.2021

Frankfurt am Main, 21.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.33

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 20.10.2021

Frankfurt am Main, 20.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.36

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 19.10.2021

Frankfurt am Main, 19.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.40

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 18.10.2021

Frankfurt am Main, 18.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.50

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 15.10.2021

Frankfurt am Main, 15.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.54

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 14.10.2021

Frankfurt am Main, 14.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.57

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 13.10.2021

Frankfurt am Main, 13.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.61

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 12.10.2021

Frankfurt am Main, 12.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.64

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 11.10.2021

Frankfurt am Main, 11.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.75

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 08.10.2021

Frankfurt am Main, 08.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.78

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 07.10.2021

Frankfurt am Main, 07.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.82

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 06.10.2021

Frankfurt am Main, 06.10.2021
Vontobel Financial Products GmbH
Announcement

Issuer: Vontobel Financial Products GmbH, Frankfurt am Main
Product name: MFS MRNA VT162
Symbol: MFS MRNA VT162
ISIN: DE000VX1XXK6

ADJUSTMENT OF PRODUCT FEATURES

The following product features were adjusted on the due date:

Stop-Loss Barrier: USD 351.19
Strike: USD 365.82

FURTHER INFORMATION
Underlying: Moderna Inc.
Underlying ISIN: US60770K1079
Underlying Bloomberg Ticker: MRNA UW Equity
Financing Spread: 3.50%
Stop-Loss Buffer: 3.999%
Reference interest rate: 0.05%

Due date: 05.10.2021

Frankfurt am Main, 05.10.2021
Vontobel Financial Products GmbH
TypDatumTitel
Barrier Events2021-10-26Barrier Event
Rule-based Parameter Adjustment2021-10-26Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-25Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-22Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-21Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-20Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-19Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-18Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-15Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-14Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-13Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-12Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-11Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-08Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-07Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-06Adjustment of Product Features
Rule-based Parameter Adjustment2021-10-05Adjustment of Product Features

Dokument